Astrazeneca Pharma India

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue257.01292.70303.56319.44315.45
Expenses217.55229.19232.16262.49295.05
EBITDA43.7867.8575.3561.1324.71
EBIT39.6623.3771.5573.8821.01
Profit Before Tax39.4523.2871.4073.3820.40
Net Profit29.3017.2753.8652.3715.80
Financial Ratios
Operating Profit Margin17.53%9.70%25.50%24.93%8.08%
Net Profit Margin11.73%17.25%18.23%13.09%5.17%
Earning Per Share (Diluted)11.726.9121.5420.956.32
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.8.2
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ